The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer
Mariusz Łochowski,Justyna Chałubińska-Fendler,Izabela Zawadzka,Barbara Łochowska,Marek Rębowski,Daniel Brzeziński,Józef Kozak
DOI: https://doi.org/10.2147/CMAR.S317705
2021-10-09
Cancer Management and Research
Abstract:Mariusz &Lstrokochowski, 1 Justyna Cha&lstrokubi&nacuteska-Fendler, 2 Izabela Zawadzka, 3 Barbara &Lstrokochowska, 4 Marek R&eogonbowski, 1 Daniel Brzezi&nacuteski, 1 Józef Kozak 1 1 Clinic of Thoracic Surgery and Respiratory Rehabilitation, Medical University of Lodz, Lodz, Poland; 2 Department of Radiotherapy, Military Institute of Medicine, Warsaw, Poland; 3 "Synevo" Medical Laboratory, Regional Multi-Specialist Center for Oncology and Traumatology of the Nicolaus Copernicus Memorial Hospital in Lodz, Lodz, Poland; 4 Department of Radiotherapy and General Oncology, Regional Multi-Specialist Center for Oncology and Traumatology of the Nicolaus Copernicus Memorial Hospital in Lodz, Lodz, Poland Correspondence: Mariusz &Lstrokochowski Email Introduction:: The aim of the study was to determine the prognostic significance of PLR and NLR ratios in patients operated due to non-small cell lung cancer. Material: The study group consisted of 532 (174 women, 358 men) patients with non-small cell lung cancer (NSCLC) staged IA-IIIA. The mean age was 63.6 years (range 36 to 84 years). Together with platelet/lymphocyte ratio (PLR) and neutrophil/lymphocyte ratio (NLR), the following factors were included in the statistical analysis: age, sex, smoking history, the number of leukocytes, neutrophils, and platelets, histopathology, T-stage, N-stage, concomitant diseases according to the Charlson Comorbidity Index (CCI), type of operation, adjuvant chemotherapy, and overall survival. Results: Univariate analysis showed an association between the value of PLR and NLR and the length of survival. Multivariate analysis found that the stage of advancement of the neoplastic disease (p=0.00003), adjuvant chemotherapy (p=0.009), CCI > 4 (0.00008), and PLR > 144 (p=0.001) were negative prognostic factors for survival > 2 years; however, this effect diminishes in patients surviving more than 5 years. Conclusion: PLR might serve as a prognostic factor in patients affected by NSCLC with expected two-year overall survival. Keywords: carcinoma, lymphocyte count, neutrophil count, non-small-cell, platelet count, ratio Lung cancer poses a serious threat, resulting in more than 1.6 million deaths worldwide annually. 1 Unfortunately, it is most often diagnosed when it is already locally advanced, and about one-fifth of the total number of cases of non-small cell lung cancer (NSCLC) can qualify for surgical treatment. Despite intensive treatment, the 5-year survival expectancy of those patients does not exceed 18%. The most important prognostic factors are undoubtedly the histopathological type of cancer and its stage, ie lymph node involvement and presence of distant metastases. 2 The majority of ongoing studies are focused on the search for other factors that can be assessed at disease onset to predict the prognosis and qualify the patient for appropriate treatment. Such studies are typically performed on a large scale, including huge panels of laboratory parameters including protein and genetic biomarkers which might indicate a biological response to oncogenesis 3,4 This biological response is accompanied by a developing inflammatory process that can be induced by serum proteins and nucleic acid products released by the tumor, eg TNF-alpha, free fractions of microRNA or free circulating DNA. Many of these molecules are undergoing testing as possible prognostic markers; however, their precise accuracy and specificity remain unknown and they are routinely used. 3 Nevertheless, it is possible to detect inflammatory processes with simple, easily available everyday tests, such as the standard complete blood count test and its calculated derivatives. 4,5 In addition, the platelet-to-lymphocyte ratio (PLR) and the neutrophil-to-lymphocyte ratio (NLR) are promising indices whose prognostic value has been discussed in cases of various malignancies. 2,4 The aim of the present study is to evaluate the prognostic value of PLR and NLR in patients receiving surgical treatment due to NSCLC. The study included 532 patients surgically treated for stage IA-IIIA NSCLC in the period 2007 to 2014. Patients with operable small cell carcinoma and carcinoid were excluded from the study. Before the operation, all the patients had had to undergo a PET examination. Patients with N2 were qualified for an operation only if the metastases involved a single node and the node was not conglomerated. The laboratory tests necessary for hospitalization were performed with a Sysmex XN 2000 flow cytometer (Sysmex Europe GmbH, Norderstedt, Germany). PLR, ie the ratio of the absolute numbe -Abstract Truncated-
oncology